Skip to main content
Figure 3 | Molecular Medicine

Figure 3

From: Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic Mice

Figure 3

Galantamine administration reduces levels of circulating pathogenic anti-insulin antibodies. Serum from galantamine- or saline-administered was applied to ELISA plates coated with antigens and then probed with anti-mouse antibodies. Serum anti-insulin antibodies were reduced in animals administered galantamine (A) (p > 0.05), but other common NOD autoantibodies were not affected (B–E).

Back to article page

Molecular Medicine

ISSN: 1528-3658